An enzyme formed by streptococci which can break down blood clots and is therefore used in the treatment of myocardial infarction.
Enzyme produced by some strains of streptococcus that liquefies blood clots by converting plasminogen to plasmin; it is used in some cases of myocardial infarction and pulmonary embolism to dissolve the clot blocking the blood vessels and restore normal blood flow. Adverse effects include hemorrhage, fever, and gastrointestinal upsets.
One of the original thrombolytic drugs. Streptokinase (Streptase) is used to dissolve blood clots that have formed in blood vessels. Streptokinase is usually prescribed when a blood clot threatens the flow of blood to certain areas of the body. It is given by injection.
An enzyme produced by some hemolytic bacteria of the genus Streptococcus that is capable of liquefying blood clots. It is injected to treat blockage of blood vessels, including infarction and pulmonary embolism. It is also used in combination with streptodornase, applied topically or taken by mouth or injection, to liquefy pus and relieve inflammation. Side-effects may include digestive upsets, fever, and hemorrhage.
An enzyme produced by certain streptococci. It acts as a plasminogen activator, and hence enhances fibrinolysis. The most important use of streptokinase is in the treatment of myocardial infarction in the first 12 hours after the initial diagnosis. Subsequently, use of this thrombolytic drug should be under hospital supervision. It is given intravenously, in hospital by infusion. It may be given as an infusion to treat severe thrombosis or embolism, particularly when they occur in a limb, and in deep venous thrombosis.
A thrombolytic medication employed to dissolve blood clots subsequent to a heart attack (myocardial infarction) or a pulmonary embolism (a clot obstructing a lung blood vessel). Streptokinase is administered under careful monitoring due to its potential to cause excessive bleeding, alongside other unfavorable outcomes like nausea, rash, and cardiac arrhythmias.